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utations in the AAA adenosine triphosphatase
(ATPase) Spastin (SPG4) cause an autosomal
dominant form of hereditary spastic paraple-
gia, which is a retrograde axonopathy primarily charac-
terized pathologically by the degeneration of long spi-
nal  neurons in the corticospinal tracts and the dorsal
columns. Using recombinant Spastin, we ﬁnd that six mu-
tant forms of Spastin, including three disease-associated
forms, are severely impaired in ATPase activity. In contrast
to a mutation designed to prevent adenosine triphosphate
(ATP) binding, an ATP hydrolysis–deﬁcient Spastin mutant
predicted to remain kinetically trapped on target proteins
M
 
decorates microtubules in transfected cells. Analysis of
disease-associated missense mutations shows that some
more closely resemble the canonical hydrolysis mutant,
whereas others resemble the ATP-binding mutant. Using
real-time imaging, we show that Spastin severs microtu-
bules when added to permeabilized, cytosol-depleted
cells stably expressing GFP-tubulin. Using puriﬁed com-
ponents, we also show that Spastin interacts directly with
microtubules and is sufﬁcient for severing. These studies
suggest that defects in microtubule severing are a cause
of axonal degeneration in human disease.
 
Introduction
 
Neurons expend considerable effort maintaining and some-
times degrading axons in response to a variety of cues. Human
genetic phenotypes afforded by diseases that are characterized
by axonal degeneration and the study of the corresponding
disease genes may shed light into the mechanisms responsible
for axonal homeostasis and neurodegenerative disorders. Muta-
tions in Spastin, an AAA ATPase that is widely expressed, are
the most common cause of the autosomal dominant heredi-
tary spastic paraplegia (Hazan et al., 1999), which is a retro-
grade axonopathy that primarily affects the corticospinal tracts
and the fasciculis gracilis characterized clinically primarily by
spastic gait (Fink, 2002).
The function of Spastin is unclear. Neuronal suppres-
sion of 
 
Drosophila melanogaster 
 
Spastin using RNAi results
in undergrowth of the neuromuscular junction and increased
synaptic currents, whereas overexpression results in decreased
currents (Trotta et al., 2004).
AAA proteins often function as oligomers, with each pro-
tomer usually containing one or two AAA ATPase modules.
These domains share several key structural motifs and are
homologous to some degree among all AAA proteins. NH
 
2
 
-
terminal domains of AAA family members that bind adaptors
or directly to target proteins are usually highly divergent and,
therefore, are determinant of specificity of cellular function.
This portion of Spastin contains an MIT domain—a domain of
unknown function (Ciccarelli et al., 2003) found in several
proteins that function in the endosome, including VPS4/SKD1
(an AAA ATPase involved in endosomal trafficking), and in
sorting nexin 15. Interestingly, another hereditary spastic para-
plegia gene, 
 
Spartin
 
, contains an MIT domain.
Although the MIT domain mediated interaction of Spastin
with the endosomal protein CHMP1B (Reid et al., 2005) raises
the possibility an endosome-related function, Spastin’s AAA
ATPase domain (Frohlich, 2001; Frickey and Lupas, 2004) is
most homologous to those found in VPS4, Fidegtin, and Katanin,
a microtubule-severing AAA ATPase (McNally and Vale,
1993). First purified from mitotic sea urchin extracts, Katanin
has been shown to play a role in microtubule reorganization at
the onset of mitosis (McNally and Vale, 1993; McNally and
Thomas, 1998). In neurons, Katanin appears to be a source of
noncentrosomal microtubules (Ahmad et al., 1999). Katanin
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overexpression in cultured mammalian neurons or in trans-
genic 
 
D. melanogaster
 
 alters process outgrowth (Karabay et
al., 2004) and results in developmental abnormalities of the
mushroom body (Nicolai et al., 2003), respectively.
Spastin overexpression in cultured cells or in 
 
D. melano-
gaster
 
 tissues results in decreased microtubule content (Errico
et al., 2002; Sherwood et al., 2004; Trotta et al., 2004) by an
unknown mechanism. Based on the homology of Spastin’s ATP-
ase domain to that found in Katanin, Spastin has been hypoth-
esized to have microtubule-severing activity. However, overex-
pression of many types of proteins including tubulin isoforms
(Bhattacharya and Cabral, 2004), tubulin folding cofactors
(Martin et al., 2000), and others (Antonsson et al., 1998) results
in decreased microtubule content. To determine the precise
mechanism by which Spastin alters microtubule content, we
used video microscopic and biochemical assays to demonstrate
that recombinant Spastin makes internal breaks along the
lengths of microtubules both with purified in vitro assembled
microtubules and when added to permeabilized cytosol ex-
tracted fibroblasts stably expressing GFP-tubulin. We show
that Spastin is sufficient for severing, and that several disease-
associated mutations in Spastin abolish both ATPase and
severing activities.
 
Results
 
Disease-associated mutations in Spastin 
abrogate ATPase activity
 
Spastin possesses a COOH-terminal AAA module, an 
 
 
 
250–
amino acid domain that contains several signature motifs
found in AAA proteins including the Walker A and B motifs
(Ogura and Wilkinson, 2001) and the arginine finger (Ogura
et al., 2004). The contribution of conserved amino acids in
these motifs to ATP binding and hydrolysis and enzyme oli-
gomerization have been elucidated by structural and muta-
tional analysis in a variety of AAA proteins. Mutation of
walker A motif P-loop residues can result in enzymes that ei-
ther fail to bind ATP or that bind but do not hydrolyze ATP.
Arginine finger mutations can result in defects in ATP hydro-
lysis or in oligomerization defects (Ogura et al., 2004). Many
missense mutations in Spastin change amino acids that are
conserved in AAA domains including Walker A and B motifs
and R-finger residues.
To determine whether the enzymatic activity of Spastin
is altered by disease-associated missense mutations, many of
which change conserved residues in the AAA domain (Fonk-
nechten et al., 2000; Lindsey et al., 2000), we produced and
purified recombinant GST-Spastin (Fig. 1 A). Recombinant
GST-Spastin hydrolyzes ATP with a K
 
m
 
 and V
 
max
 
 in the range
for those reported for other AAA ATPases (Fig. 1, B–D). None
of the three disease-associated mutants tested had significant
enzymatic activity (Fig. 1 E). Two of these mutations are in the
P-loop (K388R and N386K), but the third involves the arginine
finger motif (R499C). Removal of the NH
 
2
 
-terminal GST tag
by site-specific proteolysis did not change ATPase activity
(not depicted). Q347K Spastin lacked activity (not depicted,
see also Fig. 2 h). Neither Spastin, with a canonical Walker A
mutation (K388A) designed to prevent ATP binding, nor Spas-
tin harboring a Walker B (E442Q) mutation designed to allow
ATP binding but prevent hydrolysis, showed any significant
activity. This suggests that the measured ATPase activity with
WT enzyme results from Spastin’s activity and not from con-
taminating ATPases.
Figure 1. Analysis of recombinant Spastin. (a) 4  g WT GST-Spastin
was electrophoresed on a 12% gel. The fusion protein runs at  95 kD.
(b) Saturation curve that shows ATPase activity of 15 nM WT GST-Spastin.
20- l reactions were incubated for 20 min at 37 C. (c) Double reciprocal
plot derived from the data in b is shown. (d) Km and Vmax were calculated
from data in c and are shown in the table and compared with published
values for other AAA ATPases; GST-SPG4 is WT Spastin (McNally and
Vale, 1993; Babst et al., 1997; Schirmer et al., 1998). (e) Mutant versions
of Spastin were prepared in parallel with WT enzyme and assayed for
ATPase activity with 1 mM ATP for 15 min at 37 C with 25 nM en-
zyme. E442Q and K388A are discussed in the Results section. The
other mutants represent disease-associated mutations. Note K388R and
N386K are located in the Walker A P-loop, and that R499C is the argi-
nine finger residue. 
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Spastin targets microtubules in 
transfected cells
 
When overexpressed, some missense mutations cause Spastin
to decorate microtubules (Errico et al., 2002). In the absence of
analyzing mutations altering predicted aspects of AAA bio-
chemistry in Spastin, the meaning of this decoration is unclear.
We undertook a systematic analysis by engineering canonical
mutations of conserved residues in the AAA domain with
known functional consequences (i.e., by homology modeling
with coordinate mutations in other AAA proteins) to better
gauge the effects of the disease mutations. In particular, an E to
Q mutation in the Walker B motif in many different AAA ATP-
ases results in enzymes that bind but do not hydrolyze ATP
(Ogura and Wilkinson, 2001). Because many AAA proteins
bind target proteins when loaded with ATP both in vitro and in
a cellular context, Walker E to Q mutations might be a useful
tool to inform about the cellular target proteins of AAA pro-
teins of unknown function. This approach has been docu-
mented to be reliable in test cases involving NSF, VCP/p97,
and VPS4 (Babst et al., 1997, 1998; Ye et al., 2001, 2003;
Dalal et al., 2004).
E442Q Spastin, which is predicted to bind but not hydro-
lyze ATP and thus remain kinetically trapped on target pro-
teins, shows a filamentous pattern (Fig. 2 b). These filaments
represent a subset of microtubules and are even observed in SW
cells that lack cytosolic intermediate filament proteins (Sarria et
al., 1994), suggesting that the filaments are indeed microtu-
bules (unpublished data). Furthermore, nocodazole treatment
abolished this pattern of Spastin fluorescence (Errico et al.,
2002; unpublished data). These results suggest that, upon ATP
binding, Spastin targets to microtubules. As a negative control,
we engineered a canonical Walker A motif P-loop mutation in-
volving an invariant Lys (position 388 in Spastin). Typically,
mutation of this Lys to Ala results in an enzyme that does not
bind ATP (Babst et al., 1998). In contrast to E442Q Spastin,
K388A Spastin does not decorate microtubules (Fig. 2 f).
We analyzed six disease-associated mutations in the
AAA domain of Spastin (Fig. 2, c–e and g–i), and observed the
microtubule pattern with K388R, N386K, and I344K. Note that
mutation of Lys 388 to Arg or Ala had different consequences
(Fig. 2, compare f with c). Because K388R more closely re-
sembled E442Q than K388A, we suggest that the K388R mu-
tant is primarily a hydrolysis deficient enzyme. The percentage
of transfected cells showing the filamentous pattern in a repre-
sentative experiment is shown in Fig. 2 j. We suggest that mu-
tations showing the filamentous pattern that resemble that seen
with E442Q engineered mutations are probably kinetically im-
paired with respect to ATP hydrolysis but bind ATP and target
to microtubules. We hypothesize that mutations showing the
punctate structures akin to that seen with K388A Spastin may
not bind ATP at all. The locations of the mutations analyzed
are shown schematically in Fig. 2 k.
Consistent with the idea that microtubules are a Spastin
target, overexpression of WT Spastin results in a decreased
steady-state number of both dynamic and stable microtubules
in transfected cells (Fig. 2 a and Fig. 3, a–d) as assessed by
staining with antibodies specific for either Tyr or detyrosinated
Glu-tubulin (Gundersen et al., 1984). We also examined the
consequences of overexpression of representative Spastin mu-
tants, including one that shows a primarily filamentous pattern
and one that shows the punctate pattern. Compared with neigh-
boring untransfected cells, the content and arrangement of both
stable and dynamic microtubules appear relatively normal in
the K388A expressing cell (Fig. 3, i–l). As seen in Fig. 2, the
Spastin mutants that showed the filamentous pattern only deco-
rated a subset of microtubules in cells, often centrally and sur-
rounding the nucleus. To determine whether this decorated
subset represents stable microtubules, we analyzed E442Q
YFP-Spastin expressing by immunofluorescence microscopy
using tubulin antibodies specific for Tyr and Glu tubulin. The
latter antibody stains stable microtubules. In the majority of
Figure 2. ATP hydrolysis deficient but not ATP binding deficient Spastin
localizes to MTs. (a–i) TC 7 cells were transiently transfected with WT or
mutant YFP-Spastin (green) for 24 h. Microtubule staining is in red. (a) WT
Spastin forms cytosolic puncta, and transfected cells show decreased
microtubule staining. (b) E442Q Spastin forms filaments that colocalize
with a subset of microtubules. The percentage of transfected cells showing
the filamentous pattern is shown in j.(f) K388A Spastin forms cytosolic
puncta like the WT enzyme, however, the MT content of transfected cells is
not decreased. Some disease-associated mutations (N386K, K388R, and
I344K) decorated microtubules (c–e), whereas others did not (R499C,
Q347K, and S362C) (g–i). (k) Schematic that shows the relative locations
of the various mutations. Note two different mutations at the same position
(K388A vs. K388R) produce different phenotypes. 
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cells examined, overexpression of E442Q Spastin results in an
increased content of stable microtubules (Fig. 3 f, compare
nontransfected cells with transfected cell). Often, but not in ev-
ery cell, the extent of Spastin colocalization with microtubules
enriched in Glu-tubulin is greater than those enriched in Tyr-
tubulin. Overexpression of Spastin mutants showing the fila-
mentous pattern also causes bundling of decorated microtu-
bules. At least in these overexpression experiments, filamen-
tous Spastin mutants appear to act like a MAP, in that they
stabilize and bundle microtubules. Similar results were ob-
tained when we stained for acetylated rather than Glu tubulin
and with other filamentous Spastin mutants (unpublished data).
 
Recombinant Spastin severs 
microtubules in permeabilized cells
 
We developed a permeabilized cell assay to visualize the ef-
fects of Spastin on microtubules. Cells were permeabilized
with low concentrations of Triton X-100 to deplete cytosol be-
fore taxol-induced microtubule stabilization. Taxol was added
to prevent the ATP-induced microtubule depolymerization that
otherwise occurs in permeabilized cells (Infante et al., 2000).
Addition of ATP and WT Spastin, but not ATP and mutant
Spastin, to permeabilized TC7 cells resulted in a time-dependent
decrease in microtubule content indicating that disassembly re-
quires ATP hydrolysis by Spastin (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200409058/DC1). To con-
firm that Spastin is responsible for the observed breaks, we
imaged  microtubules in real time during incubations with
Spastin (Fig. 4 and Videos 1–3). Permeabilized, cytosol-de-
pleted NIH 3T3 cells stably expressing GFP-tubulin were incu-
bated with WT or E442Q Spastin, as indicated in the figure leg-
end. Reactions were initiated by addition of ATP to 0.25 mM.
In incubations with mutant enzyme, no loss of microtubules
was observed even after 12 min (Fig. 4 g, and Video 3). In con-
trast, initiation of WT-containing reactions with ATP resulted
in severing of nearly all microtubules in the cell (Fig. 4, a–f;
and Videos 1 and 2). Once the reaction started, it proceeded
rapidly with all microtubules being affected to a similar degree.
Breaks (Fig. 4, e and f, arrows) seem to appear internally with
no obvious preference for one end or the other of microtubules.
 
Spastin-mediated microtubule severing 
with purified components
 
We next used videomicroscopy to monitor severing of purified
rhodamine-labeled microtubules that had been immobilized in
glass perfusion chambers with an ATP hydrolysis deficient 
 
D.
melanogaster
 
 (E164A) kinesin which in the presence of ATP
binds to microtubules with increased affinity compared with
WT enzyme (Klumpp et al., 2003). As shown in Fig. 5, WT
Spastin resulted in the appearance of breaks in microtubules
over the course of the experiment, whereas incubation with
E442Q ATP hydrolysis–deficient Spastin (Fig. 5, h and i did
not result in severing over the 32 min of the experiment). After
severing, ends of microtubules were sometimes mobile with re-
leased microtubule fragments sometimes being perfused away
(Videos 4 and 5, available at http://www.jcb.org/cgi/content/
Figure 3. Analysis of stable and dynamic microtubules in Spastin-expressing cells. Cos-7 cells were transiently transfected with YFP-Spastin constructs
(green), WT (a–d), E442Q (e–h), or K388A (i–l) for 24 h. After methanol fixation, cells were stained for both Glu-tubulin (visualized with Cy-3–labeled
secondary antibody; red) and Tyr-tubulin (visualized with Cy-5 labeled secondary antibody; blue). Compared with neighboring cells, WT Spastin overex-
pression results in decreased content of both stable and dynamic microtubules. Expression of the E442Q mutant shows that Spastin decorates microtubules
and causes an increase in stable microtubules compared with nontransfected cells. Also, the microtubule organizing center appears less distinct in these
cells. Expression of K388A Spastin does not appear to alter microtubule content or arrangement. 
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full/jcb.200409058/DC1). In each panel, some of the new
breaks are marked with arrowheads. This experiment demon-
strates that ATP hydrolysis by Spastin is sufficient for microtu-
bule severing. As expected for a severing enzyme and consis-
tent with the transfection data in Figs. 2 and 3, we found that
E442Q Spastin binds along the lengths of the immobilized mi-
crotubules (Fig. S2).
We also used an established cosedimentation assay (Mc-
Nally and Vale, 1993) to ascertain whether Spastin is suffi-
cient for microtubule severing. Taxol-stabilized microtubules
were assembled in vitro. A large fraction of the tubulin poly-
merized as assessed by sedimentation (Fig. 6, lanes 15 and
16). In the absence of ATP, WT Spastin sedimented with the
microtubules indicating that Spastin associates with microtu-
bules even in the absence of ATP, as is the case for Katanin
(McNally and Vale, 1993), and slightly increased the amount
of tubulin recovered in the pellet (Fig. 6, lanes 1, 2, 9, and 10).
In contrast, when the same experiment is performed in the
presence of 1 mM ATP (Fig. 6, lanes 3 and 4), most of the
tubulin was recovered in the supernatant fraction, and this in-
dicates that Spastin severed a large fraction of the microtubules.
Additionally, Spastin does not sediment in the absence of
polymerized microtubules. We also confirmed that ATP does
not alter the fraction of tubulin that pellets nor does Spastin
pellet in the absence of tubulin (unpublished data). ATP did
not induce microtubule disassembly with either E442Q (Fig.
6, lanes 5 and 6) or K388A Spastin (Fig. 6, lanes 7 and 8)
showing that hydrolysis of ATP by Spastin is required and
sufficient for microtubule severing in vitro. Both mutant en-
zymes were recovered in the pellet fractions. The binding of
K388A Spastin again suggests that ATP binding is not re-
quired for microtubule association in vitro. Neither AMP-PNP
(Fig. 6, lanes 11 and 12) nor ADP (Fig. 6, lanes 13 and 14) al-
lowed for WT Spastin-induced severing. The graph shows
quantitation from the gels. Note that the two gels shown are
from representative, independent experiments performed with
the same lot of microtubules and Spastin. Although generally
reproducible, recovery of tubulin could vary by as much as
20% from sample to sample, precluding a more quantitative,
detailed analysis of kinetics.
Although some AAA proteins, including Katanin, show
substrate-induced increases in ATPase activity (Matveeva and
Whiteheart, 1998; Hartman and Vale, 1999; Cashikar et al.,
2002), we have not detected any microtubule-related change in
Spastin’s activity (unpublished data). Whereas, in transfected
cells, only YFP-E442Q and not YFP-K388A Spastin colocal-
Figure 4. Spastin severs taxol-stabilized microtubules in permeabilized
cells. (a–d) Extracted NIH 3T3 cells stably transfected with GFP-tubulin
were permeabilized and microtubules were taxol stabilized before addi-
tion of WT-Spastin to 80 nM. After selecting a field to image, 0.25 mM
ATP was added at time 0. Selected frames of the time-lapse are shown
(min:s). (a) Whole-cell image (see Video 1, available at http://www.
jcb.org/cgi/content/full/jcb.200409058/DC1). Panels b–d show a re-
gion delineated by the large box in panel a. In this case, microtubule sev-
ering is observed 5 min after the addition of ATP, and it occurs very rap-
idly (3 min). (e and f) Magnification of the two smaller boxed areas
marked in panel a; arrows point to individual microtubules breaks (see
Video 2). g. No severing occurs in a cell incubated with E442Q mutant
and ATP even after 12 min (see Video 3). Bar, 10  m.
Figure 5. Spastin severs purified microtubules in vitro. Rhodamine-labeled
microtubules were assembled and immobilized in perfusion chambers con-
taining ATP and an oxygen-scavenging system as described in Materials
and methods. 100 nM WT GST-Spastin (a–g) or E442Q GST-Spastin in
buffer containing ATP were perfused into the chambers, and images were
acquired over a 20-min (WT incubation) or 32-min period (E442Q incu-
bation). Selected frames are shown with the time (min:s) shown in each
panel. Individual breaks in microtubules are first seen 1:47 min after addi-
tion of Spastin to the chamber (b) and continue to occur throughout 17
min (c–g). Arrowheads mark some of the new breaks observed in each
frame. No breaks occur in incubations with ATP-hydrolysis deficient Spastin
(h and i). The complete videos (Videos 4 and 5) are available at http://
www.jcb.org/cgi/content/full/jcb.200409058/DC1. Some movement
of microtubules is seen because of movement of liquid in the chamber,
and some severed fragments are washed away. 
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ized with microtubules (Figs. 2 and 3), both mutants bind to
microtubules in vitro. Although the nature of the discrepancy is
unclear, it is possible that ATP-loaded Spastin has a higher af-
finity for microtubules than ATP-free enzyme and that the rela-
tively high concentrations of enzyme we use in vitro to visual-
ize the enzyme in gels may be near saturating. By estimating
the staining intensities of Coomassie-stained gels, it appears
that Spastin is capable of binding microtubules with an approx-
imate stoichiometry of 
 
 
 
1 mol Spastin to 1 mol tubulin. This is
consistent with the data in Fig. S2 that demonstrates Spastin
binding along the length of the microtubule.
 
Discussion
 
We demonstrated that Spastin is a microtubule-severing en-
zyme that can act directly on microtubules and that several dis-
ease-associated mutations impair the enzymatic activity of
Spastin. By comparison to immunofluorescence patterns ob-
tained with canonical Walker A and Walker B mutations, we
suggest that some disease-causing mutations impair ATP bind-
ing, whereas others are likely impaired at the ATP hydrolysis
step of the reaction cycle.
It is currently unclear whether the two severing enzymes
subserve different functions. Nevertheless, our demonstration
that a second AAA ATPase is capable of microtubule severing
suggests that cells use this means of regulating microtubule dy-
namics in a broad array of circumstances. Both Katanin and
Spastin are expressed in a wide variety of neurons and nonneu-
ronal tissues (Hazan et al., 1999; Charvin et al., 2003; Wharton
et al., 2003; Karabay et al., 2004). Though Katanin and Spastin
share the ability to make internal breaks in microtubules, they
only share homology in the AAA region and their NH
 
2
 
-termi-
nal regions are quite distinct. This might indicate use of distinct
adaptor proteins or may indicate different biochemical mecha-
nisms of action.
Whereas the precise role of Spastin in unclear, the disease
phenotype where axons of some long neurons degenerate after
apparently normal central nervous system development sug-
gests that the microtubule-severing activity may be important
in axonal maintenance and that Katanin is not able to compen-
sate for Spastin deficiency in this circumstance. The recent
finding that loss of 
 
D. melanogaster
 
 Spastin paradoxically re-
sults in decreased microtubule content at the neuromuscular
junction with resultant decreases in transmitter release suggests
that Spastin may be required for maintenance of axon terminals
(Sherwood et al., 2004).
A growing number of neurodegenerative disorders are
linked to microtubule function. Mutations in microtubule mo-
tors including KIF5a (Reid, 2003) and dynein complex compo-
nents (Puls et al., 2003) cause hereditary spastic paraplegia
and motor neuron degeneration, respectively. Tau, a microtu-
bule-associated protein, is mutated in chromosome 17–linked
fronto-temporal dementia and accumulates in neurofibrillary
tangles in Alzheimer’s disease (Lee et al., 2001). Abnormali-
ties of microtubule destabilizing enzymes can now be consid-
ered capable of contributing to neurodegeneration.
 
Materials and methods
 
Production of recombinant Spastin
 
HeLa mRNA was prepared using the Oligotex kit (QIAGEN). After per-
forming RT-PCR (Omniscript; QIAGEN), Spastin cDNA was cloned into
pGEX6p-3 for production of recombinant protein in 
 
Escherichia coli
 
 or
into pEYFP-C1. Mutations were engineered with the QuikChange (Strat-
agene) kit. GST-Spastin was produced in BL21DE3 pLys 
 
E. col
 
i (RILP cells;
Stratagene). LB cultures containing carbenecillin, streptomycin, and chlor-
amphenicol were grown at 37
 
 
 
C to an OD
 
600nm
 
 of 1.0. 0.4 mM IPTG and
2% ethanol were added, and the cultures were grown for 48 h at 16
 
 
 
C.
Washed cells in 25 ml of lysis buffer (50 mM Hepes/KOH, pH 7.4, 150
mM NaCl, 5 mM MgCl
 
2
 
, 5% glycerol, and 2 mM ATP) supplemented with
an EDTA-free protease inhibitor cocktail (Roche) were lysed with an ho-
mogenizer (Emulsiflex model C-5; Avestin) operating in an ice bath at
15,000–20,000 psi. The lysate was adjusted to 1% Triton X-100 and cen-
Figure 6. Spastin is sufficient for severing MTs. Taxol-stabilized MTs
were assembled from purified tubulin GTP and taxol and incubated with
recombinant Spastin and nucleotides as indicated in the figure. After 10
min at 37 C, microtubules were separated from tubulin dimer by ultracen-
trifugation. In the absence of ATP, WT GST-Spastin sediments with micro-
tubules (lanes 1 and 9), indicating direct binding. In contrast, with ATP,
most of the tubulin was recovered in the supernatant fraction (lane 4), in-
dicating that severing occurred. Note that Spastin does not sediment non-
specifically (lane 4). E442Q and K388A mutant Spastin sediment with
microtubules but do not sever even in the presence of ATP (lanes 5 and 7).
These results suggest that ATP hydrolysis is required for severing. Neither
AMP-PNP nor ADP could substitute for ATP (lanes 11 and 13). The two
panels represent separate experiments. (top gel) White line indicates that
intervening lanes have been spliced out. Quantitation of the data from the
gels is shown in the bar graph. 
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trifuged (Ti60 rotor [Beckman Coulter]; 50,000 rpm, for 50 min, at 4
 
 
 
C)
and pumped over a 1-ml glutathione-Sepharose column (Amersham Bio-
sciences). After washing with 10 volumes of lysis buffer containing 500
mM NaCl and 20 volumes of lysis buffer containing 0.1% Triton X-100,
150 mM NaCl and lacking ATP, Spastin was eluted using a linear gradi-
ent of 0–20 mM glutathione in enzyme buffer (50 mM Hepes, 150 mM
NaCl, 5 mM MgCl
 
2
 
, 5% glycerol, and 0.1% Triton X-100). In some cases,
Spastin was further purified by binding to SP-Sepharose (1 ml HiTrap col-
umn) and eluted with 500 mM NaCl in enzyme buffer. The GST moiety
was removed with Precision Protease (Amersham Biosciences).
 
Malachite green ATPase assay
 
ATPase activity was measured using the malachite green colorimetric as-
say using sodium phosphate as a standard. Reactions (typically 20 
 
 
 
l)
containing the concentrations of enzyme and ATP indicated in the figures
were incubated at 37
 
 
 
C for the times indicated in the figures. Next, the
absorbance (OD
 
650nm
 
) was recorded. Finally, the absorbances of control
samples containing the same amount of ATP, but lacking the enzyme,
were subtracted from all values.
 
Transfection, cell culture, and immunofluorescence
 
TC7 or NIH 3T3 cells stably transfected with GFP-tubulin were maintained
in DME supplemented with 10% FCS, penicillin, and streptomycin at 37
 
 
 
C
with 5% CO
 
2
 
. For transient transfections, cells were grown on coverslips
in 12-well dishes and transfected with YFP-Spastin constructs using Trans-
fectin (Bio-Rad Laboratories). After 24–48 h, cells were rinsed and fixed
with methanol for 5 min at 
 
 
 
20
 
 
 
C. Cells were blocked in TBS containing
10% normal donkey serum and 0.2% Triton X-100 for 1 h at room temper-
ature. Primary antitubulin antibody (YL1/2 [Chemicon] or anti–Glu-tubulin
[Gundersen et al., 1984] 1:500 dilution) was diluted in blocking buffer
and applied to cells for 1 h at 25
 
 
 
C. After three 5-min washes, secondary
antibody (Cy-3– or Cy-5–labeled donkey anti–rat; Jackson ImmunoRe-
search Laboratories) was applied for 1 h at 25
 
 
 
C. Still images were ob-
tained using an Optiphot (Nikon) with a 60
 
 
 
 objective. Photographs
were obtained using a cooled CCD camera (Princeton Instruments) and
processed using Metamorph software.
 
Microtubule-severing assay in permeabilized cells
 
TC 7 or NIH 3T3 cells were rinsed three times in prewarmed PEM buffer at
37
 
 
 
C on a heating block, and then were permeabilized by addition of
prewarmed PEM containing 0.2% Triton X-100 for 60 s. After aspiration,
the microtubules in the permeabilized cells were stabilized by addition of
PEM containing 10 
 
 
 
M taxol. Cells were rinsed in PEM/taxol, and all fur-
ther manipulations were performed at 37
 
 
 
C.
For severing reactions, recombinant Spastin in enzyme buffer was
diluted to 80 nM in PEM buffer. This mixture was added to cells and reac-
tions were initiated by adding ATP to 0.25 mM or the concentration indi-
cated in the figures. Reactions were stopped by removal of the enzyme
and fixation in cold methanol. Microtubule content was assessed either by
immunofluorescence or real-time imaging of GFP-tubulin.
 
Microtubule severing with fluorescently labeled microtubules
 
We used similar conditions to those described in Hartman et al. (1998).
Flow cells were constructed by taping coverslips together with strips of
double-sided tape placed 5 mm apart. Chambers hold 
 
 
 
10–15 
 
 
 
l. The
chambers were first perfused with 10 
 
 
 
l of 15 
 
 
 
M of mutant rigor kinesin
(E164A) provided by Susan Gilbert (University of Pittsburgh, Pittsburgh,
PA). After 10 min, chambers were blocked with 10 
 
 
 
l of 1 mg/ml casein.
Next, microtubules were assembled by incubating tubulin and rhodamine-
tubulin at a ratio of 9:1 (Cytoskeleton, Inc.) at a final concentration of 2
mg/ml in PEM buffer (Pipes, pH 6.95, 1 mM EDTA, and 2 mM MgCl
 
2
 
)
with 1 mM GTP and 20 
 
 
 
M taxol for at least 1 h at 37
 
 
 
C. These were di-
luted 10-fold before perfusion. Rhodamine-labeled microtubules (10 
 
 
 
l of
0.2 mg/ml stock) were perfused into chambers. After 3 min, chambers
were washed with 50 
 
 
 
l PEM buffer containing 1 mM ATP, and with an
oxygen-scavenging cocktail to prevent photodamage (220 
 
 
 
g/ml glucose
oxidase, 22.5 mM glucose, 36 
 
 
 
g/ml catalase, and 71.5 mM 
 
 
 
-mercap-
toethanol). After selecting a field to image, chambers were perfused with
80 nM GST-Spastin in PEM buffer containing 10 
 
 
 
M taxol, the oxygen-
scavenging cocktail, and 1 mM ATP.
 
Imaging E442Q Spastin bound to microtubules
 
Unlabeled microtubules were immobilized on kinesin-coated coverslips
as described in the preceding paragraph and perfused with 100 nM
GST-E442Q Spastin or 100 nM GST alone. After 5 min of binding,
chambers were washed three times and fixed for 3 min at 25
 
 
 
C with 1%
glutaraldehyde. Samples were stained for tubulin (Tyr-tubulin–specific
antibody) and for GST (Amersham Biosciences).
 
Time-lapse video microscopy
 
Cells or perfusion chambers were transferred to a microscope (model
TE300; Nikon), equipped with a heated (34
 
 
 
C) chamber and a 60
 
 
 
 (1.4
NA) plan Apo lens. Epifluorescence images were collected with a camera
(model CoolSnap HQ; Roper Scientific). The exposure time was controlled
with a Lambda 10–2 filter changer (Sutter Instruments) driven by Meta-
morph (Universal Imaging Corporation). Images were processed with a
low-pass filter.
 
Microtubule binding assay
 
Microtubules were assembled by incubating tubulin (Cytoskeleton, Inc.) at
0.2 mg/ml in PEM buffer with 1 mM GTP and 20 
 
 
 
M taxol for at least
1 h at 37
 
 
 
C. 5 
 
 
 
l of microtubules was added to each reaction containing
recombinant 1 
 
 
 
g WT or mutant Spastin and ATP as indicated in the fig-
ures. Reactions were performed in PEM buffer, and the final volume
was 50 
 
 
 
l. After 10 min at 37
 
 
 
C, microtubules were separated from solu-
ble tubulin by ultracentrifugation (TL100 rotor [Beckman Coulter]; run at
50,000 rpm for 10 min, 37
 
 
 
C, 100,000 
 
g
 
av
 
). Equal portions of pellet and
supernatant fractions were analyzed by SDS-PAGE.
 
Online supplemental material
 
Fig. S1 shows Spastin-mediated severing in permeabilized TC7 cells. Fig.
S2 shows that recombinant E442Q Spastin binds along the length of puri-
fied microtubules. Five videos are available online (Videos 1–5). In Videos
1–3 microtubules in permeabilized NIH 3T3 cells stably expressing GFP-
tubulin were imaged in real time. Video 1 shows a cell incubated with WT
Spastin; Video 2 shows a region of detail from the cell imaged in Video1;
and Video 3 shows a cell incubated with mutant Spastin. The complete
videos for the data in Fig. 5 are shown in Videos 4 and 5. Video 4 shows
incubations with WT enzyme, whereas Video 5 shows an incubation with
mutant E442Q Spastin. Legends and methods for the videos are available
online at http://www.jcb.org/cgi/content/full/jcb.200409058/DC1.
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